Deutsche Bank’s NRX Pharmaceuticals NRXP Stock Holding History

Deutsche Bank’s Portfolio NRXP Stock Details NRXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-20	Closed	-$2K	–	4591
2021 Q2	$2K	Buy	+20	New	+$5.28K	﹤0.01%	4547

Other funds holding NRXP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

OCAM

Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HAG

HighPoint Advisor Group Downers Grove, Illinois $2.39B AUM 28.86% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Deutsche Bank's NRXP Position: Q3 2021 in Review

Deutsche Bank sold out of NRX Pharmaceuticals (NRXP) in Q3 2021, closing a stake of 20 shares — an estimated $2K sold.

Deutsche Bank first reported a position in NRXP in Q2 2021 and held it in 1 quarter. The position peaked at $2K in Q2 2021. 23 funds tracked by Wall St. Rank hold NRXP as of Q3 2021.

Deutsche Bank reported no remaining NRX Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
Deutsche Bank sold 20 NRX Pharmaceuticals shares in Q3 2021, an estimated $2K.
Deutsche Bank first reported a position in NRX Pharmaceuticals in Q2 2021 and held it in 1 quarter.
Deutsche Bank's NRX Pharmaceuticals position peaked at $2K in Q2 2021.
23 funds tracked by Wall St. Rank held NRX Pharmaceuticals as of Q3 2021.

Based on Deutsche Bank's 13F filing for Q3 2021, filed 4 Nov 2021.